Company intelligence / Profile preview

FabGennix

Frisco, Texas, United States of Americafabgennix.com ↗

Ownership: Private
Employees: ~12
Development stage: Commercial

Overview

FabGennix is not developing therapeutics; it supplies validated antibodies and reagents widely cited in peer-reviewed publications. Their products support preclinical/basic science work across multiple fields but do not have clinical results as they are tools for researchers rather than drugs or therapies themselves.

Therapeutic areas: OncologyCardiovascularMetabolic DisordersNeurology
Modalities: AntibodyPeptidesProteinReagent
Industry: Chemicals & Materials

Partnerships

BIOZOLEnzo Life Sciences

Beyond the preview

Go deeper on FabGennix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FabGennix.

Explore the full profile